Audientes CEO: We have the perfect product for the future OTC channel

Hearing aid firm Audientes is seeing dollar signs on the future OTC market for hearing aids in the US. For this reason, the firm is now doing everything in its power to get low-cost hearing aids approved by the US Food and Drug Administration.

Audientes CEO Steen Thygesen | Photo: Audientes / PR

The US is undoubtably the largest single market in the hearing industry, and when the new regulation on over-the-counter sales of hearing aids is implemented, probably in a few years' time, sales will blossom for the companies that are selling low-cost hearing devices.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs